- Home
- » Tags
- » Estrogen receptor
Top View
- MYC-Driven Pathways in Breast Cancer Subtypes
- 17Β-Estradiol Upregulates the Expression of Peroxisome
- Molecular Dynamics of Estrogen Receptors
- P53: Protection Against Tumor Growth Beyond Effects on Cell Cycle and Apoptosis Xuyi Wang1,2, Evan R
- Expression of Wilm's Tumor Gene (WT1) in Endometrium with Potential Link to Gestational Vascular Transformation
- Wilms' Tumor 1 Suppressor Gene Mediates Antiestrogen Resistance Via Down-Regulation of Estrogen Receptor-A Expression in Breas
- Role of Peroxisome Proliferator-Activated Receptor Γ and Estrogen Receptors in Mediating the Anti-Mitogenic Actions of Phytoestrogens
- Differential Expression of Estrogen Receptor Α, Β1, and Β2 in Lobular and Ductal Breast Cancer
- PPAR-Mediated Toxicology and Applied Pharmacology
- Estrogen and Progesterone Receptors in the Normal Female Breast D
- Altered Expression of the WT1 Wilms Tumor Suppressor Gene in Human Breast Cancer
- Regulation of Neural Gene Expression by Estrogen Receptor Alpha
- Peroxisome Proliferator-Activated Receptor Γ As a Therapeutic Target in Human Breast Cancer Julie M
- Maternal Behavior Stimulates C-Fos Activity Within Estrogen Receptor Alpha-Containing Neurons in Lactating Rats
- Estrogen Receptor Corepressors – a Role in Human Breast Cancer?
- Involvement of Estrogen Receptor &Beta
- Effectively Target Estrogen Receptor Positive Human Breast Cancers
- The Prognostic Role of Androgen Receptor in Patients with Early
- Epithelial C-Jun and C-Fos Are Temporally and Spatially Regulated by Estradiol During Neonatal Rat Oviduct Differentiation
- Transcriptional Regulation of Estrogen Receptor-A by P53 in Human Breast Cancer Cells
- Regulation of Tumor Suppressor Proteins, P53 and Retinoblastoma, by Estrogen and Antiestrogens in Breast Cancer Cells
- Study of the Role of Estrogen Receptor Variant, Era36, in Non Genomic Signaling and Breast Cancer Soleilmane Omarjee
- Genome-Wide Mapping of Estrogen Receptor-Β–Binding Regions Reveals Extensive Cross-Talk with Transcription Factor Activator Protein-1
- Estrogen Actions in Triple-Negative Breast Cancer
- A Systematic Comparison of Three Commercial Estrogen Receptor
- Original Article Hypomethylation of DNA-Binding Inhibitor 4 Serves As a Potential Biomarker in Distinguishing Acquired Tamoxifen-Refractory Breast Cancer
- Estrogen Receptor and Progesterone Receptor Are Prognostic Factors in Soft Tissue Sarcomas
- Estrogen Receptor Beta (ER) Regulation of Lipid Homeostasis
- Low Levels of Estrogen Receptor Protein Predict Resistance To
- Epigenetic Regulation of ID4 in Breast Cancer: Tumor Suppressor Or
- Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
- Stimulation of C-Myc Oncogene Expression Associated with Estrogen-Induced Proliferation of Human Breast Cancer Cells1
- ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer
- ID4 Controls Luminal Lineage Commitment in Normal Mammary Epithelium and Inhibits BRCA1 Function in Basal-Like Breast Cancer
- Androgen and Estrogen Receptor Expression in the Developing
- Somatic Loss of Estrogen Receptor Beta and P53 Synergize to Induce Breast
- Endocrine Resistance in Breast Cancer: the Role of Estrogen Receptor Stability
- Identification of Estrogen-Responsive Genes Based on the DNA Binding Properties of Estrogen Receptors Using High-Throughput Sequencing Technology
- Immunoreactivity for C-Kit and P63 As an Adjunct in the Diagnosis of Adenoid Cystic Carcinoma of the Breast
- Estrogen Receptor Prevents P53-Dependent Apoptosis in Breast Cancer